Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026)
Sera Prognostics (SERA) posted Cash & Equivalents of $4.2 million for Q1 2026, up 5.86% on a QoQ basis from $3.9 million in Q4 2025, and down 20.17% year-over-year from $5.2 million in Q1 2025.
Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026) Analysis & Trends
Sera Prognostics' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- Quarterly Cash & Equivalents fell 20.17% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 20.17% YoY) and the FY2025 annual result came in at $3.9 million, down 2.45% from the prior year.
- Cash & Equivalents was $4.2 million for Q1 2026 at Sera Prognostics, up from $3.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $64.1 million in Q1 2022 and bottomed at $2.7 million in Q3 2024.
- A 5-year average of $17.5 million and a median of $5.0 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents sank 87.01% — and 2025, when it jumped 52.05%.
- Sera Prognostics' Cash & Equivalents stood at $29.9 million in 2022, then sank by 87.01% to $3.9 million in 2023, then climbed by 4.2% to $4.0 million in 2024, then slipped by 2.45% to $3.9 million in 2025, then climbed by 5.86% to $4.2 million in 2026.
- Business Quant data shows SERA's Cash & Equivalents at $4.2 million in Q1 2026, $3.9 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | 557.00 Mn |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 3.03 Bn |
| 10 | Sera Prognostics | 103.03 Mn | 103.03 Mn | -28,000.00 | 4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.18 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 9.66 Mn |
| Jun 30, 2023 | 32.29 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 29.88 Mn |
| Sep 30, 2022 | 38.81 Mn |
| Jun 30, 2022 | 53.89 Mn |
| Mar 31, 2022 | 64.10 Mn |
| Dec 31, 2021 | 58.93 Mn |
| Sep 30, 2021 | 82.50 Mn |
| Jun 30, 2021 | 90.90 Mn |